Trial Profile
Three-Year Safety and Efficacy Outcomes in Kidney Transplant Patients Randomized to Steroid Avoidance or Maintenance Steroids with Early Intensified Dosing of Enteric-Coated Mycophenolate Sodium: The INFINITY Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 May 2013
Price :
$35
*
At a glance
- Drugs Corticosteroids (Primary) ; Mycophenolate sodium (Primary) ; Ciclosporin; Interleukin-2
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms INFINITY
- 31 May 2013 New trial record